These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8077154)

  • 21. Long-term patient monitoring for clozapine-induced agranulocytosis and neutropenia in Korea: when is it safe to discontinue CPMS?
    Kang BJ; Cho MJ; Oh JT; Lee Y; Chae BJ; Ko J
    Hum Psychopharmacol; 2006 Aug; 21(6):387-91. PubMed ID: 16933201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimizing clozapine treatment.
    Naber D
    J Clin Psychiatry; 1999; 60 Suppl 12():35-8. PubMed ID: 10372609
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety evaluation of the concomitant use of clozapine and benzodiazepines: a retrospective, cross-sectional chart review.
    Bitter R; Demler TL; Opler L
    J Psychiatr Pract; 2008 Sep; 14(5):265-70. PubMed ID: 18832957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Do white-cell count spikes predict agranulocytosis in clozapine recipients?
    Alvir JM; Lieberman JA; Safferman AZ
    Psychopharmacol Bull; 1995; 31(2):311-4. PubMed ID: 7491384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clozapine-induced agranulocytosis: non-cross-reactivity with other psychotropic drugs.
    Lieberman JA; Johns CA; Kane JM; Rai K; Pisciotta AV; Saltz BL; Howard A
    J Clin Psychiatry; 1988 Jul; 49(7):271-7. PubMed ID: 3391979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical use of clozapine in a major urban setting: one year experience.
    Chow EW; Collins EJ; Nuttall SE; Bassett AS
    J Psychiatry Neurosci; 1995 Mar; 20(2):133-40. PubMed ID: 7703222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of clozapine-induced granulocytopenia/agranulocytosis with granulocyte-colony stimulating factor (G-CSF) in an intellectually disabled patient with schizophrenia.
    Rajagopal G; Graham JG; Haut FF
    J Intellect Disabil Res; 2007 Jan; 51(Pt 1):82-5. PubMed ID: 17181606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prescribing patterns and the use of therapeutic drug monitoring of psychotropic medication in a psychiatric high-security unit.
    Castberg I; Spigset O
    Ther Drug Monit; 2008 Oct; 30(5):597-603. PubMed ID: 18708990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Neutropenia in a patient treated with clozapine in combination with other psychotropic drugs].
    Sénéchal A; Landry P; Deschamps R; Lessard M
    Encephale; 2002; 28(6 Pt 1):567-9. PubMed ID: 12506270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Retrospective study of clozapine use in Ile-de-France].
    Hiltgen S; Mantelet S; Pinabel F; Enjaume F
    Encephale; 2006 Oct; 32(5 Pt 1):688-96. PubMed ID: 17099592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of clozapine on medication use in a state hospital.
    Schalk DC; Wilson WH
    Hosp Pharm; 1993 Jul; 28(7):647-53. PubMed ID: 10127299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myoclonus in patients treated with clozapine: a case series.
    Bak TH; Bauer M; Schaub RT; Hellweg R; Reischies FM
    J Clin Psychiatry; 1995 Sep; 56(9):418-22. PubMed ID: 7665541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Agranulocytosis in the course of clozapine treatment].
    Załuska M; Gajewska J
    Psychiatr Pol; 1995; 29(1):67-77. PubMed ID: 7878156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-desmethylclozapine, an insensitive marker of clozapine-induced agranulocytosis and granulocytopenia.
    Combs MD; Perry PJ; Bever KA
    Pharmacotherapy; 1997; 17(6):1300-4. PubMed ID: 9399615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clozapine: an exclusive treatment?].
    Vanelle JM
    Encephale; 1992 Sep; 18 Spec No 3():441-5. PubMed ID: 1339761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reducing clozapine-related morbidity and mortality: 5 years of experience with the Clozaril National Registry.
    Honigfeld G; Arellano F; Sethi J; Bianchini A; Schein J
    J Clin Psychiatry; 1998; 59 Suppl 3():3-7. PubMed ID: 9541331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tolerability and efficacy of clozapine combined with lithium in schizophrenia and schizoaffective disorder.
    Small JG; Klapper MH; Malloy FW; Steadman TM
    J Clin Psychopharmacol; 2003 Jun; 23(3):223-8. PubMed ID: 12826983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The incidence of clozapine-induced leukopenia in patients with schizophrenia at Srinagarind Hospital.
    Maskasame S; Krisanaprakornkit T; Khiewyoo J
    J Med Assoc Thai; 2007 Oct; 90(10):2175-80. PubMed ID: 18041439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Patient knowledge regarding Clozapine-induced agranulocytosis].
    Haberfellner EM; Rittmannsberger H
    Psychiatr Prax; 2006 May; 33(4):194-6. PubMed ID: 16680627
    [No Abstract]   [Full Text] [Related]  

  • 40. Clozapine use in female geriatric patients with psychoses.
    Chengappa KN; Baker RW; Kreinbrook SB; Adair D
    J Geriatr Psychiatry Neurol; 1995 Jan; 8(1):12-5. PubMed ID: 7710640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.